Nanomedicine is no longer a commitment to the future, but a reality more and more extended. Among its applications, researchers use it to obtain early diagnosis of different diseases, more efficient drugs and alternative therapies to the most aggressive treatments. "http://www.expoquimia.com/" Expoquimia, the reference event in the chemical industry, will have a space dedicated exclusively to nanomedicine, as in the "http://www.vhir.org/salapremsa/mitjans/mitjans_detall.asp?Idioma=en&mv1=5&mv2=1&mh1=0&mh2=0&mh3=0&mh4=0&ms=0&any=2011&num=336" last successful edition. The Vall d’Hebron Institute of Research (VHIR), which comprises and area dedicated to nanomedicine, is the organizer of this debate about the present and the future of nanomedicine, led by outstanding scientists and pharmacists. The meeting will take place on October 2 at Expoquimia and will deal with the current state of nanomedicine, personalized medicine and biomarkers. Participants will also focus in the perspectives of translation of the results to the society. Chaired by VHIR’s director, Dr. Joan Comella, three lecturers will participate in the meeting: Dr. Josep Tabernero, head of the Oncology Service at the Vall d’Hebron University Hospital, Dr. Víctor Franco, ICREA professor and researcher of the Catalan Institute of Nanoscience and Nanotechnology (ICN2), and Dr. Artur Palet, director of Business Development in Spain of Roche Diagnostics. "http://www.vhir.org/activitats/relacioactivitats_detall.asp?Idioma=ca&any=2014&num=152&mv1=4&mv2=1&titol=Jornada+sobre+nanomedicina,+me" More information